Three cases of OXA-48-like carbapenemase producing Enterobacteriaceae (not) detected using Xpert^® Carba-R

References

• Huang T-D, Berhin C, Bogaerts P, Glupczynski Y. On behalf of a multicentre study group. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium. JAC. 2013;68:1832–7.
   Google Scholar
• Huang T-D, Poirel L, Bogaerts P, Berhin C, Nordmann P, Glupczynski Y. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. JAC. 2014;69:445–50.
   Google Scholar
• Lafeuille E, Laouira S, Sougakoff W, Soulier-Escrihuela O, Leconte J, Garrec H, et al. Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement. Int J Antimicrob Agents. 2015;45:441–2.10.1016/j.ijantimicag.2014.12.009
   PubMed Web of Science ®Google Scholar
• Decousser JW, Poirel L, Desroches M, Jayol A, Denamur E, Nordmann P. Failure to detect carbapenem-resistant Escherichia coli producing OXA-48-like using the Xpert Carba-R assay®. Clin Microbiol Infect. 2015;21:e9–e10.10.1016/j.cmi.2014.09.006
   PubMed Web of Science ®Google Scholar
• Findlay J, Hopkins KL, Meunier D, Woodford N. Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria. J Antimicrob Chemother. 2015;70:1338–42.10.1093/jac/dku571
   PubMed Web of Science ®Google Scholar
• Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY antimicrobial surveillance program, 2006–2007. Antimicrob Agents Chemother. 2011;55:1274–8.10.1128/AAC.01497-10
   PubMed Web of Science ®Google Scholar
• Balm MN, La MV, Krishnan P, Jureen R, Lin RT, Teo JW. Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases. Clin Microbiol Infect. 2013;19:E421–E423.10.1111/1469-0691.12247
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. M100-S25. Wayne (PA): CLSI; 2015.
   Google Scholar
• Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. JAC. 2012;67:906–9.
   Google Scholar
• Bogaerts P, Rezende de Castro R, de Medonça R, Huang T-D, Denos O, Glupczynski Y. Validation of carbapenemase and extended-spectrum β-lactamase multiplex endpoint PCR assays according to ISO 15189. JAC. 2013;68:1576–82.
   Google Scholar
• Oueslati S, Nordmann P, Poirel L. Heterogeneous hydrolytic features for OXA-48-like β-lactamases. JAC. 2015;70:1059–63.
   Google Scholar
• Potron A, Rondinaud E, Poirel L, Belmonte O, Boyer S, Camiade S, et al. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae. Int J Antimicrobial Agents. 2013;41:325–9.10.1016/j.ijantimicag.2012.11.007
   PubMed Web of Science ®Google Scholar
• Bakthavatchalam YD, Anandan S, Veeraraghavan B. Laboratory detection and clinical implication of Oxacillinase-48 like carbapenemase: the hidden threat. Glob Infect Dis. 2016;8(1):41–50.
   PubMed Web of Science ®Google Scholar
• Glupczynski Y, Evrard S, Ote I, Mertens P, Huang T-D, Leclipteux T, et al. Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria. J Antimicrob Chemother. 2016;71:1217–22.10.1093/jac/dkv472
   PubMed Web of Science ®Google Scholar
• Dortet L, Jousset A, Sainte-Rose V, Cuzon G, Naas T. Prospective evaluation of the OXA-48 K-seT assay, an immunochromatographic test for the rapid detection of OXA-48-type carbapenemases. J Antimicrob Chemother. 2016;71:1834–40. 10.1093/jac/dkw058
   PubMed Web of Science ®Google Scholar